Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 594.07 Million EUR | 5.26% |
| 2022 | 559.77 Million EUR | 15.19% |
| 2021 | 485.96 Million EUR | 6.37% |
| 2020 | 456.87 Million EUR | -7.54% |
| 2019 | 494.15 Million EUR | 13.0% |
| 2018 | 437.3 Million EUR | -15.83% |
| 2017 | 519.52 Million EUR | -22.3% |
| 2016 | 668.61 Million EUR | -3.95% |
| 2015 | 696.07 Million EUR | 9.53% |
| 2014 | 635.48 Million EUR | 6.23% |
| 2013 | 598.22 Million EUR | -0.13% |
| 2012 | 599 Million EUR | 6.69% |
| 2011 | 561.46 Million EUR | -0.08% |
| 2010 | 561.9 Million EUR | 1.0% |
| 2009 | 556.34 Million EUR | -3.52% |
| 2008 | 576.62 Million EUR | 2.61% |
| 2007 | 561.97 Million EUR | 5.65% |
| 2006 | 531.89 Million EUR | 10.6% |
| 2005 | 480.92 Million EUR | 6.42% |
| 2004 | 451.89 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 285.55 Million USD | -0.51% |
| 2023 FY | 589.21 Million EUR | 5.26% |
| 2023 Q4 | 279.37 Million USD | 90.56% |
| 2023 Q3 | 146.6 Million EUR | -50.85% |
| 2023 Q2 | 298.29 Million USD | 88.04% |
| 2023 Q1 | 158.63 Million EUR | -40.69% |
| 2022 Q2 | 135.7 Million USD | 0.0% |
| 2022 Q4 | 267.48 Million USD | 110.52% |
| 2022 FY | 559.77 Million EUR | 15.19% |
| 2022 Q1 | 135.7 Million EUR | 28.68% |
| 2022 Q3 | 127.05 Million EUR | -6.37% |
| 2021 Q3 | 105.46 Million EUR | -16.72% |
| 2021 Q2 | 126.63 Million USD | 0.0% |
| 2021 FY | 485.96 Million EUR | 6.37% |
| 2021 Q1 | 126.63 Million EUR | 17.17% |
| 2021 Q4 | 105.46 Million USD | 0.0% |
| 2020 Q3 | 108.07 Million EUR | -4.65% |
| 2020 FY | 456.87 Million EUR | -7.54% |
| 2020 Q1 | 113.35 Million EUR | -16.55% |
| 2020 Q2 | 113.35 Million USD | 0.0% |
| 2020 Q4 | 108.07 Million USD | 0.0% |
| 2019 Q3 | 135.83 Million EUR | -49.79% |
| 2019 Q1 | 242.35 Million EUR | 128.11% |
| 2019 FY | 494.15 Million EUR | 13.0% |
| 2019 Q2 | 270.53 Million EUR | 11.63% |
| 2019 Q4 | 135.83 Million USD | 0.0% |
| 2018 Q3 | 106.24 Million EUR | -10.77% |
| 2018 Q4 | 106.24 Million EUR | 0.0% |
| 2018 FY | 437.3 Million EUR | -15.83% |
| 2018 Q1 | 119.06 Million EUR | -46.67% |
| 2018 Q2 | 119.06 Million EUR | 0.0% |
| 2017 Q1 | 143.83 Million EUR | -38.94% |
| 2017 Q4 | 223.27 Million EUR | 0.0% |
| 2017 Q3 | 223.27 Million EUR | 55.23% |
| 2017 FY | 519.52 Million EUR | -22.3% |
| 2017 Q2 | 143.83 Million EUR | 0.0% |
| 2016 FY | 668.61 Million EUR | -3.95% |
| 2016 Q2 | 180.07 Million EUR | 0.0% |
| 2016 Q4 | 235.54 Million EUR | 0.0% |
| 2016 Q3 | 235.54 Million EUR | 30.81% |
| 2016 Q1 | 180.07 Million EUR | 8.28% |
| 2015 FY | 696.07 Million EUR | 9.53% |
| 2015 Q4 | 166.3 Million EUR | 2.27% |
| 2015 Q3 | 162.61 Million EUR | -15.62% |
| 2015 Q2 | 192.72 Million EUR | 11.37% |
| 2015 Q1 | 173.04 Million EUR | 11.55% |
| 2014 Q1 | 157.11 Million EUR | 8.99% |
| 2014 Q4 | 155.13 Million EUR | 2.91% |
| 2014 Q3 | 150.74 Million EUR | -12.16% |
| 2014 Q2 | 171.62 Million EUR | 9.23% |
| 2014 FY | 635.48 Million EUR | 6.23% |
| 2013 FY | 598.22 Million EUR | -0.13% |
| 2013 Q2 | 163.29 Million EUR | 6.43% |
| 2013 Q4 | 144.15 Million EUR | 5.05% |
| 2013 Q1 | 153.43 Million EUR | -1.74% |
| 2013 Q3 | 137.21 Million EUR | -15.97% |
| 2012 Q1 | 150.93 Million EUR | 9.05% |
| 2012 Q3 | 136.91 Million EUR | -15.09% |
| 2012 Q4 | 156.14 Million EUR | 14.05% |
| 2012 FY | 599 Million EUR | 6.69% |
| 2012 Q2 | 161.25 Million EUR | 6.84% |
| 2011 Q2 | -151.09 Million EUR | -199.73% |
| 2011 Q4 | 138.4 Million EUR | 10.64% |
| 2011 FY | 561.46 Million EUR | -0.08% |
| 2011 Q3 | 125.1 Million EUR | 182.79% |
| 2011 Q1 | 151.51 Million EUR | 15.0% |
| 2010 Q2 | 152.4 Million EUR | 1.96% |
| 2010 FY | 561.9 Million EUR | 1.0% |
| 2010 Q3 | 128.48 Million EUR | -15.69% |
| 2010 Q1 | 149.47 Million EUR | 13.57% |
| 2010 Q4 | 131.74 Million EUR | 2.54% |
| 2009 Q1 | 155.46 Million EUR | 0.0% |
| 2009 FY | 556.34 Million EUR | -3.52% |
| 2009 Q4 | 131.61 Million EUR | 7.13% |
| 2009 Q3 | 122.85 Million EUR | -16.48% |
| 2009 Q2 | 147.08 Million EUR | -5.39% |
| 2008 FY | 576.62 Million EUR | 2.61% |
| 2007 FY | 561.97 Million EUR | 5.65% |
| 2006 FY | 531.89 Million EUR | 10.6% |
| 2005 FY | 480.92 Million EUR | 6.42% |
| 2004 FY | 451.89 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | -20647.683% |
| Ansell Limited | 495.5 Million USD | -19.894% |
| Ansell Limited | 495.5 Million USD | -19.894% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 82.8 Million USD | -617.448% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 1.73 Million USD | -34224.538% |
| Psykey, Inc. | 1.21 Million USD | -48856.225% |
| ConvaTec Group Plc | 910.31 Million USD | 34.74% |
| ConvaTec Group Plc | 872.5 Million USD | 31.911% |
| Encision Inc. | 3.77 Million USD | -15629.788% |
| Golden Valley Development, Inc | 141.81 Thousand USD | -418819.548% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | -540306.255% |
| Innovative MedTech Inc. | 6.09 Million USD | -9640.513% |
| LifePoint, Inc. | 7.42 Million USD | -7902.214% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | -9256.97% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | -69382.339% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 726.13 Thousand USD | -81713.274% |
| Reflect Scientific, Inc. | 1.06 Million USD | -55749.822% |
| SmileDirectClub, Inc. | 517 Million USD | -14.907% |
| Sector 10, Inc. | 39.84 Thousand USD | -1490899.9% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 91.057% |
| SheerVision, Inc. | 2.33 Million USD | -25378.859% |
| United Health Products, Inc. | 2.42 Million USD | -24382.359% |
| Vasamed, Inc. | 4.67 Million USD | -12613.138% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | -23089.674% |
| Yubo International Biotech Limited | 1.25 Million USD | -47128.381% |